These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35867762)

  • 1. Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11.
    Zhang L; Hobeika CS; Khabibullin D; Yu D; Filippakis H; Alchoueiry M; Tang Y; Lam HC; Tsvetkov P; Georgiou G; Lamb C; Stone E; Puigserver P; Priolo C; Henske EP
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2122840119. PubMed ID: 35867762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma.
    Priolo C; Khabibullin D; Reznik E; Filippakis H; Ogórek B; Kavanagh TR; Nijmeh J; Herbert ZT; Asara JM; Kwiatkowski DJ; Wu CL; Henske EP
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6274-E6282. PubMed ID: 29891694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of gamma-glutamyltransferase 1 in glioblastoma cells confers resistance to cystine deprivation-induced ferroptosis.
    Hayashima K; Katoh H
    J Biol Chem; 2022 Mar; 298(3):101703. PubMed ID: 35148992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromophobe renal cell carcinoma: New genetic and metabolic insights.
    Zhang L; Henske EP
    Urol Oncol; 2020 Aug; 38(8):678-681. PubMed ID: 32444178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies.
    Xiao Y; Meierhofer D
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
    Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
    Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for gamma-glutamyl transpeptidase in the transport of cystine into human endothelial cells: relationship to intracellular glutathione.
    Cotgreave IA; Schuppe-Koistinen I
    Biochim Biophys Acta; 1994 Jul; 1222(3):375-82. PubMed ID: 7913623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression.
    Chen WJ; Pan XW; Song X; Liu ZC; Xu D; Chen JX; Dong KQ; Di SC; Ye JQ; Gan SS; Wang LH; Zhou W; Cui XG
    Cancer Lett; 2024 Jul; 593():216963. PubMed ID: 38768682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocytosis-Mediated Replenishment of Amino Acids Favors Cancer Cell Proliferation and Survival in Chromophobe Renal Cell Carcinoma.
    Xiao Y; Rabien A; Buschow R; Amtislavskiy V; Busch J; Kilic E; Villegas SL; Timmermann B; Schütte M; Mielke T; Yaspo ML; Jung K; Meierhofer D
    Cancer Res; 2020 Dec; 80(24):5491-5501. PubMed ID: 33115803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
    He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
    J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy for chromophobe renal cell carcinoma: A systematic review.
    Papanikolaou D; Ioannidou P; Koukourikis P; Moysidis K; Meditskou S; Koutsoumparis D; Hatzimouratidis K; Hatzivassiliou E
    Urol Oncol; 2020 Apr; 38(4):137-149. PubMed ID: 31953002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gigantol exerts anti-lung cancer activity by inducing ferroptosis via SLC7A11-GPX4 axis.
    Chen P; Lv X; Zheng Z
    Biochem Biophys Res Commun; 2024 Jan; 690():149274. PubMed ID: 37995455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patulin disrupts SLC7A11-cystine-cysteine-GSH antioxidant system and promotes renal cell ferroptosis both in vitro and in vivo.
    Chen H; Cao L; Han K; Zhang H; Cui J; Ma X; Zhao S; Zhao C; Yin S; Fan L; Hu H
    Food Chem Toxicol; 2022 Aug; 166():113255. PubMed ID: 35772596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
    Skala SL; Wang X; Zhang Y; Mannan R; Wang L; Narayanan SP; Vats P; Su F; Chen J; Cao X; Siddiqui J; Argani P; Cieślik MP; Giordano TJ; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Eur Urol; 2020 Jul; 78(1):63-74. PubMed ID: 32299640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms.
    Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C
    Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Nectin-4 in Chromophobe Renal Cell Carcinoma in a Multicenter Cohort: Early Prognostic and Therapeutic Considerations.
    Mikuteit M; Zschäbitz S; Autenrieth M; Weichert W; Hartmann A; Steffens S; Erlmeier F
    Oncology; 2024; 102(6):503-509. PubMed ID: 38043528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.